Absci Investor Presentation Deck
VALUE CREATION FOR PATIENTS AND PARTNERS - TODAY
Unlocking new and
differentiated
Higher Potential
Biologics with
Increased Pos
Multidimensional
optimization in parallel
creates higher quality
biologics with an increased
Probability of Success
SELECTIVITY
NATURALNESS
AFFINITY
ABSCI CORPORATION 2023 ALL RIGHTS RESERVED
value drivers
Reducing Time &
Increasing
Competitiveness
Drug creation process
significantly shortened
reducing research costs and
increasing competitiveness
414
Novel biology: Multi-
valent biologics &
conditional biologics
Preclinical development:
Cross-species binding to
improve success rates & speed
MOUSE-AG
HUMAN-AG
(
CYNO-AG
Broadening
Intellectual
Property Space
Al-driven drug creation
generates valuable IP
absci. 40View entire presentation